SCHEMBL16827334

SCHEMBL16827334

COc1ccc2c(c1)CCN(c1ccc(C(C)C)cc1F)C2=O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 5/20 0.46
▸ SRD5A1 P18405 1/20 0.41
▸ MAPK14 Q16539 3/20 0.40
▸ NOTUM Q6P988 1/20 0.40
▸ ACACB O00763 1/20 0.39
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39
▸ GPR84 Q9NQS5 2/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ APP P05067 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ HTR2B P41595 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16848256 0.87 AOC3 (0.46) AOC3SRD5A1MAPK14NOTUMPRMT5
SCHEMBL16827445 0.84 AOC3 (0.49) AOC3SRD5A1MAPK14NOTUMGPR84
SCHEMBL16827416 0.84 AOC3 (0.46) AOC3SRD5A1MAPK14NOTUMPRMT5
SCHEMBL16827452 0.82 AOC3 (0.47) AOC3SRD5A1PRMT5WDR77DRD2
SCHEMBL22725975 0.82 AOC3 (0.62) AOC3SRD5A1MAPK14PRMT5WDR77
SCHEMBL29438630 0.82 AOC3 (0.62) AOC3SRD5A1MAPK14PRMT5WDR77
SCHEMBL16827489 0.81 AOC3 (0.46) AOC3SRD5A1MAPK14NOTUMPRMT5
SCHEMBL16827516 0.81 AOC3 (0.44) AOC3SRD5A1MAPK14NOTUMGPR84
SCHEMBL16827514 0.80 AOC3 (0.48) AOC3SRD5A1MAPK14NOTUM
SCHEMBL16848199 0.80 AOC3 (0.44) AOC3PRMT5WDR77DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
Send feedback